Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Thursday, November 9, 2017

FDA Approves Once-Weekly Bydureon BCise (exenatide) for Patients with Type-2 Diabetes

›
 In continuation of my update on exenatide . AstraZeneca announced that the US Food and Drug Administration (FDA) has approved ...
Tuesday, November 7, 2017

New molecule could become first treatment against chemotherapy-induced neuropathy

›
IDIBELL Researchers of the Neuro-Oncology Unit of Bellvitge University Hospital - Catalan Institute of Oncology, led by Dr. Jordi Br...
Monday, November 6, 2017

Yoga can be beneficial to people with lung cancer and their caregivers

›
In a feasibility trial of people with advanced lung cancer receiving radiation therapy, and their caregivers, yoga was beneficial to bot...
Friday, November 3, 2017

FDA Approves Ascor (Ascorbic Acid Injection, USP) for the Treatment of Scurvy

›
McGuff Pharmaceuticals, Inc., a wholly owned subsidiary of McGuffCompany, Inc. announces the United States Food and Drug Administration’s ...
Thursday, November 2, 2017

FDA Approves Verzenio (abemaciclib) for Certain Advanced or Metastatic Breast Cancers

›
  We know that, Abemaciclib is a kinase inhibitor for oraladministration. It is a white to  yellow powder with the empirical formul...
Friday, October 27, 2017

Dietary supplement could be promising therapeutic target for seizure disorders

›
We know that, Glucosamine    is an  amino sugar  and a prominent precursor in the  biochemical  synthesis of  glycosylated  proteins and l...
Monday, October 16, 2017

Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis Knee Pain

›
In continuation of my update on  Zilretta   Flexion Therapeutics, Inc. announced,  that  Food and Drug Administration (FDA) approv...
Friday, October 13, 2017

FDA Approves Lyrica CR (pregabalin) Extended-Release Tablets for Neuropathic Pain Conditions

›
In continuation of my update on Pregabalin Pfizer Inc.  announced today that the  Food and Drug Administration (FDA) has approved Lyrica CR ...
Tuesday, September 26, 2017

Heparin promotes food intake and body weight gain in animal models

›
In continuation of my update on Heparin ..... ....................................... Heparin is a medication widely used to prevent...
Monday, September 25, 2017

Mild pain killer blocks action of key protein required for hearing

›
In continuation of my update on ' diflunisal ' A Rice University study has found that the aspirin-like drug diflunisal b...
Friday, September 22, 2017

Cancer drug may inhibit growth of cysts in patients with inherited form of kidney disease

›
In continuation of my update on bostinib A cancer drug called bosutinib may inhibit the growth of cysts in patients with autosomal domi...
Thursday, September 21, 2017

New drug shows promising results for treating spinal muscular atrophy

›
A drug developed by an Iowa State University biomedical researcher as a potential treatment for spinal muscular atrophy showed promising r...
Wednesday, September 20, 2017

Two anticlotting medicines better at reducing bleeding risk than triple therapy

›
A major international study has found that the combination of two drugs - rivaroxaban and aspirin -- is superior to aspirin alone in preve...
Tuesday, September 19, 2017

Combo immunotherapy may herald new standard of care for kidney cancer

›
Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20 percent to 40 percent, a new...
Monday, September 18, 2017

Sorafenib effect on HCC survival depends on hepatitis status

›
For patients with advanced unresectable hepatocellular carcinoma, the effect of sorafenib on overall survival (OS) is dependent on patient...
‹
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.